Skip to main content
PLOS Global Public Health logoLink to PLOS Global Public Health
. 2023 Dec 5;3(12):e0002667. doi: 10.1371/journal.pgph.0002667

Potential risk factors for cardiovascular diseases and associated sociodemographic characteristics: A cross-sectional evaluation of a large cohort of women living with HIV in north-central Nigeria

Olufemi Ajumobi 1, Ijeoma Uchenna Itanyi 2,3, Amaka Grace Ogidi 3, Samantha A Slinkard 4, Echezona Edozie Ezeanolue 3,*
Editor: Julia Robinson5
PMCID: PMC10697517  PMID: 38051752

Abstract

Males have a higher prevalence of cardiovascular (CVD) risk factors such as alcohol use, hypercholesterolemia, hypertension, obesity, and smoking based on limited data available from two tertiary health centers in Nigeria. Increasing age and lower educational level influence smoking among the same population in northeastern and northwestern Nigeria. Specifically in women living with HIV (WLHIV), the association between demographic characteristics and CVD risk factors has not been described. In a multi-center cross-sectional study, we documented the association of sociodemographic characteristics with potential CVD risk factors among a large cohort of WLHIV attending five treatment sites in north-central Nigeria. This was a cross-sectional study among 5430 women of reproductive age who received antiretrovirals at five selected treatment sites in Benue State, Nigeria. We performed multivariable regression of sociodemographic characteristics on potential cardiovascular risk factors, namely, smoking, alcohol consumption, and contraceptive use. We found participants’ mean age was 33.2 (standard deviation: 6.1) years. Prevalence of smoking, alcohol consumption, and contraceptive use were 0.6%, 11%, and 7% respectively. Older WLHIV (≥ 40 years) had a negative association with contraceptive use (aOR: 0.58, 95%CI: 0.42–0.81). Being educated WLHIV had a positive association with contraceptive use (aOR: 1.34, 95%CI: 1.02–1.76) and a negative association with tobacco smoking (aOR: 0.37, 95%CI: 0.16–0.83). Being a farmer had a negative association with alcohol consumption (aOR: 0.43, 95%CI: 0.35–0.52) and contraceptive use (aOR: 0.61, 95%CI: 0.48–0.76). Compared to being married, being in a single relationship had positive association with alcohol consumption (aOR: 1.30, 95%CI: 1.08–1.56) while parenting was associated with 165% higher odds of contraceptive use (aOR: 2.65, 95%CI: 1.73–4.06). In conclusion, the low prevalence of smoking exists among women living with HIV on antiretroviral treatment. Older age, farming and being married are potential deterrents to lifestyle risk factors for cardiovascular diseases among this population. To improve HIV-related treatment efforts and outcomes, implementing interventions aimed at lifestyle behavioral modification among this population has the potential to reduce cardiovascular disease risks.

Introduction

Cardiovascular diseases have become a major health concern for persons living with HIV (PLHIV) especially because antiretroviral therapy (ART) is more accessible than it was two decades ago and has contributed to living longer with the disease. Among other factors, chronic immune activation and inflammation associated with HIV contribute to cardiovascular atherosclerosis [1]. Globally, the burden of cardiovascular disease has tripled over the past two decades [2]. In Nigeria, common cardiovascular (CVD) risk factors are hypertension, dyslipidemia, and low physical activity [3, 4].

Among both antiretroviral (ARV) naïve and PLHIV receiving routine highly active antiretroviral treatment (HAART), males have a higher prevalence of CVD risk factors such as alcohol use, diabetes mellitus, dyslipidemia, hypercholesterolemia, hypertension, obesity, and smoking [37]. These data were limited to a tertiary health center each in a state in the northern and southern part of Nigeria and these were not representative of those states. Increasing age and lower educational level are risk factors for smoking among mainly male PLHIV surveyed in single health facilities in northeastern and north-western Nigeria [7, 8]. But the influence of these factors on smoking and other potential CVD risk factors may differ among female PLHIV in other zones of the country. Additionally, the influence of occupation, marital status, and parenthood on the development of potential CVD risk factors among PLHIV in Nigeria has not been established. Our multi-center study documented the prevalence of smoking, alcohol consumption, and contraceptive use among a large cohort of women living with HIV (WLHIV) in north-central Nigeria and the association with sociodemographic characteristics.

Methods

Study context, design, and participants

The current study leveraged the scale-up of an integrated mhealth intervention for a cohort of HIV-infected women of reproductive age receiving care at five comprehensive HIV treatment centers in Benue State, Nigeria. The development of the integrated mHealth platform was described in a previous study [9]. Summarily, the mHealth platform could store encrypted patient information on a patient-held smartcard and smartphone mobile application, which is linked with a secure web-based engagement management database [9, 10]. Patient records can be viewed on the mobile app without an internet connection, and this aids in healthcare decision-making at the point of care in low-resource settings [10]. Benue State has an estimated total population of 5,138,531, of whom 49.6% are female. Most of the population resides in rural areas and the majority, about 75%, are farmers [11]. About 70% of the female population has less than a secondary school education with a literacy rate of 52.8% [12].

Each study site was selected based on (1) designation as a a comprehensive HIV treatment facility, (2) receipt of funding support from US President’s Emergency Plan for AIDS Relief (PEPFAR) through Caritas Nigeria, (3) records of a high volume of HIV-infected women (≥ 2000 women on treatment), and (4) provision of free HIV testing services, antiretroviral therapy for both adults and children and services for prevention of mother-to-child transmission (MTCT). There were 21 comprehensive HIV treatment facilities in Benue State, seven of which had at least 2000 women on treatment. Administrative leads of five out of these seven facilities gave approval for participation in the study and those facilities were selected. All HIV-infected women were eligible to participate in this study if they were of reproductive age (18–45 years) and received ART from any of the five selected study sites.

Data collection

Trained health workers offered pre-printed mhealth smartcards with unique patient identifiers to all eligible HIV-infected women as they presented for their routine pre-scheduled clinic appointments. The study’s purpose and procedures were explained to potential participants and those who gave written informed consent were chosen to participate in the study.

Trained research assistants administered pretested semi-structured questionnaires to the study participants and collected information on the sociodemographic and clinical characteristics, and lifestyle habits. Sociodemographic characteristics included age, marital status, the highest level of education, occupation, and the number of living children. Clinical characteristics included the current ART regimen, use of contraceptives, whether the participant was currently pregnant, and whether antenatal care was received for the current pregnancy. Participants were also asked about their tobacco smoking and alcohol habits. This study was carried out between June and December 2017.

Data analysis

Data on 5430 WLHIV were analyzed using SAS version 9.4. We described participants’ sociodemographic characteristics and the prevalence of clinical characteristics and potential cardiovascular risk factors. Potential risk factors for CVD are age-related and a cut-off of 40 years has been used in prior studies cut-off [6, 7]. Other than age, the association between independent variables such as education (educated/none), occupation (farmers/non-farmers), and having children (≥1/none) [13], and potential cardiovascular risk factors, namely, smoking, alcohol consumption, and contraceptive use (coded: Yes/No) were examined at bivariate and multivariable logistic regression analyses. Results were presented using odds ratio (OR) and adjusted OR. We assessed the fitness of each of our models using the global null hypothesis test leveraging the approach in previous studies and there were no issues of multicollinearity [14, 15]. Statistical significance was considered at a p-value of less than 0.05.

Ethical considerations

Ethical approval for this study was obtained from the Health Research Ethics Committee of the University of Nigeria Teaching Hospital (NHREC/05/01/2008B-FWA00002458-1RB00002323). Approval was obtained from the health administrators of all the study sites and written informed consent was obtained from participants.

Results

The mean age of participants was 33.2 (standard deviation [SD]: 6.1) years. Most were married (66.9%, n = 3632), completed high school education (24.3%, n = 1317), were married (6.9%, n = 3632), were farmers (68.4%, n = 3712), and had an average of 3 children (SD: 2), see Table 1.

Table 1. Sociodemographic characteristics of HIV-infected women in Benue, Nigeria (N = 5430).

Characteristics n (%)
Age
18–20 61 (1.1%)
21–25 545 (10.0)
26–30 1247 (23.0)
31–35 1614 (29.7)
36–40 1175 (21.6)
41–45 788 (14.5)
Marital status
Single 614 (11.3)
Married 3632 (66.9)
Divorced 430 (7.9)
Widowed 754 (13.9)
Number of children
None 683 (12.6)
1–2 1851 (34.1)
3–4 1696 (31.2)
5+ 1200 (22.1)
Highest educational level attained
None 1532 (28.2)
Completed primary 1337 (24.6)
Completed junior secondary 869 (16.0)
Completed senior secondary 1018 (18.8)
Completed post-secondary 299 (5.5)
Some post-secondary 375 (6.9)
Occupation
Civil Servant 333 (6.1)
Farmer 3712 (68.4)
Trader 998 (18.4)
Applicant 146 (2.7)
Other* 241 (4.4)
Alcohol consumption
Yes 590 (10.9)
No 4840 (89.1)
Cigarette smoking
Yes 30 (0.6)
No 5400 (99.4)
Secondhand smoke (n = 4169)
daily 665 (16.0)
weekly 19 (0.5)
monthly 6 (0.1)
less than once a month 2 (0.1)
never 3477 (83.4)

Other

*: fashion designers, hairdressers, health workers, housewives, midwives, public servants, students, and tailors

Cardiovascular risk factors

Regarding social/lifestyle characteristics, nearly all participants (99.4%, n = 5400) were non-smokers. The prevalence of cigarette smoking and alcohol was 0.6% and 10.9% respectively. About 16.7% (n = 692) of the participants experienced secondhand/passive smoking (Table 1). Overall, 5360 participants had one out of three potential cardiovascular risk factors: cigarette smoking, alcohol consumption, and contraceptive use, 70 had any two of three factors and none had the three risk factors.

Clinical characteristics

Overall, 7% (379/5430) were using contraceptives, 4.9% (264/5430) were pregnant and 66.3% (175/264) were attending antenatal care. Of the 5430 WLHIV, 5387 (99.2%) were currently on ART regimens. Of these, 5084 (94.4%) were still receiving first-line antiretroviral therapy, with two-thirds receiving tenofovir + Lamivudine + Efavirenz combination (4%) and one-third receiving Zidovudine + Lamivudine + Nevirapine combination (Table 2).

Table 2. Clinical characteristics of HIV-infected women in Benue, Nigeria (N = 5430).

Characteristics n (%)
Use contraceptives
No 5051 (93.0)
Yes 379 (7.0)
Currently pregnant
Yes 264 (4.9)
No 5166 (95.1)
Attending ANC (n = 264) 175 (66.3%)
Category of ART regimen (n = 5387)
1st line 5084 (94.4)
2nd line 303 (5.6)
Current ART regimen (n = 5387)
TDF/3TC/EFV 3432 (63.7)
AZT/3TC/NVP 1648 (30.6)
TDF/3TC/LOP/r 142 (2.6)
AZT/3TC/LOP/r 134 (2.5)
TDF/3TC/ATV/r 15 (0.3)
AZT/3TC/ATV/r 5 (0.1)
ABC/3TC/LOP/r 6 (0.1)
ABC/3TC/EFV 4 (0.1)
ABC/3TC/ATV/r 1 (0.0) *

*Rounding-off value

Smoking, alcohol consumption, and contraceptives use and associated factors

In multivariable analysis after controlling for other variables, being educated had 63% lower odds of smoking. Being a farmer had 57% lower odds of alcohol consumption while a single relationship increased the odds of alcohol consumption by 30%.

Those who were 40 years and above had 42% lower odds of contraceptive use unlike the educated who had 34% higher odds of contraceptive use. Being a farmer had 39% lower odds of contraceptive use while parenting had 165% higher odds of contraceptive use (Table 3).

Table 3. Sociodemographic characteristics associated with smoking, alcohol consumption, and contraceptive use among HIV-infected women in Benue, Nigeria.

Characteristics Smoking Alcohol Contraceptive
OR (95%CI) aOR (95%CI) OR (95%CI) aOR (95%CI) OR (95%CI) aOR (95%CI)
Age ≥ 40 vs 18–39 0.68 (0.24–1.97) 0.64 (0.22–1.87) 0.95 (0.76–1.19) 1.02 (0.81–1.28) 0.57 (0.41–0.79) * 0.58 (0.42–0.81) *
Education Educated vs none 0.51 (0.25–1.06) 0.37 (0.16–0.83) * 1.37 (1.12–1.67) * 1.00 (0.80–1.24) 1.59 (1.23–2.05) * 1.34 (1.02–1.76) *
Occupation Farmers vs non-farmers 0.70 (0.33–1.44) 0.52 (0.23–1.18) 0.42 (0.36–0.50) * 0.43 (0.35–0.52) * 0.60 (0.48–0.74) * 0.61 (0.48–0.76) *
Marital status Single relationship vs married 1.17 (0.56–2.47) 1.09 (0.51–2.36) 1.40 (1.17–1.67) * 1.30 (1.08–1.56) * 0.92 (0.73–1.15) 1.00 (0.79–1.26)
Parenthood Parent vs childless adult 0.72 (0.27–1.88) 0.77 (0.28–2.12) 0.85 (0.67–1.09) 1.15 (0.88–1.49) 2.12 (1.40–3.20) * 2.65 (1.73–4.06) *

*Statistically significant at p <0.05

Discussion

Our data revealed the prevalence of potential CVD risk factors in decreasing order of frequency: alcohol consumption, contraceptive use, passive smoking, and cigarette smoking. Education and having at least a child were independent risk factors for contraceptive use but older age and being a farmer were protective. Unlike single relationship status, engagement in farming was protective against alcohol consumption. Being educated was a disincentive to cigarette smoking. The demographic factors were associated with the outcomes, namely, contraceptive use, alcohol consumption, and smoking, but not causally related.

The low prevalence of current smoking (0.6%) reported in this study is similar to that reported among WLHIV in Ogbomosho, South-West Nigeria, and half of that reported in northern Nigeria [3]. However, this is the least prevalent potential CVD risk factor among female PLHIV in our study compared to a range of zero prevalence found in Osogbo, South-West Nigeria and Kano North-West Nigeria, 2% in Ghana (Western-Africa), 6% in rural Uganda (Eastern-Africa) and 13% in Klerksdorp, South Africa [3, 8, 1621]. Appiah and colleagues reported a pooled current smoking prevalence of 1.3% in 28 low-and-middle-income countries excluding Nigeria, South Africa, and Ghana [16]. The low prevalence of smoking among women might be because generally, women in sub-Saharan Africa are less likely to smoke and especially WLHIV [19, 22].

Alcohol consumption is a public concern among WLHIV because of the potential for disease progression [23, 24]. The 11% prevalence of alcohol consumption is lower compared to that reported in South Africa (15%) and globally (female: pooled [13.4%]) but higher than 1.1% reported among WLHIV attending the Ladoke Akintola University of Technology Teaching Hospital in Ogbomosho, a sub-urban HIV care center in South-West Nigeria [3, 21, 25]. The relatively high prevalence of alcohol consumption is concerning. Alcohol use may impair judgment, reduce risk perception, cause disinhibition, and increase the likelihood of unprotected sexual behavior [26, 27]. Also, alcohol use is associated with the reduced efficacy of ARV drugs and medication non-compliance, and therefore, educating PLHIV on these potential consequences is critical [5, 28].

The low prevalence of contraceptive use among our study population would have been a concern for MTCT in our study population but for the fact that nearly all were on HAART. Higher use of intrauterine devices (26.7%) and male condoms (29.1%) have been reported elsewhere [29, 30].

Benue is an agrarian state known as the food basket of the nation [31]. The observed protective effect of farming against alcohol consumption in our study could be because farmers are usually too busy with planting, harvesting, and marketing their products for economic gain. Alcohol consumption is commoner in the evenings by which time farmers are tired from the day’s work on the farm. Additionally, they may not want to risk the progression of disease with alcohol use [27]. However, farming did not foster contraceptive use in our study population. Contraception discourages childbearing and farming, being labor-intensive and non-mechanized, farmers tend to have a large family size. In our study, participants had an average of three children.

Age is a determinant of CVD risk [4, 6]. The decreased likelihood of contraceptive use with older age contrasts with the finding in non-HIV women of reproductive age [32]. However, it is unclear why increasing age is associated with lower odds of contraceptive use.

The single relationship remained a positive predictor of alcohol consumption. In a single relationship, alcohol use may help fill the void of stable companionship which could easily be met with cohabitation in the Western world but is strictly forbidden in the African setting based on sociocultural and religious norms [33, 34] In the African sociocultural landscape, a marital relationship provides social support which is often necessary for a PLHIV [35].

Being a parent had almost three times higher odds of contraceptive use compared to being a childless woman living with HIV. In African society, bringing forth new offspring where zero mother-to-child transmission of HIV cannot be guaranteed is undesirable. Thus, child spacing with contraceptive use is a rational decision to prevent unintended pregnancies and new HIV infections [36]. While elimination remains a target for sub-Saharan Africa, it remains a mirage until optimal MTCT services and sustained access to ARV are guaranteed. Currently, in Nigeria, access to ART is largely donor-driven [37]. Thus, in our study, that being educated fostered contraceptive use, was not a surprise [37].

In our study, education was protective against smoking unlike in prior studies in northern Nigeria which revealed the more educated you were, the higher your odds of smoking [8]. Higher educational attainment and literacy rates are twice as high in Benue State (middle-belt region of Nigeria) compared to other states in northern Nigeria [38]. These correlate with health education and might be responsible for the very low prevalence of cigarette smoking because of the prevailing belief that smokers are liable to die young.

Limitations of the study

This study had limitations. The degree of alcohol consumption (drinks/week) and cigarette smoking (pack years) was not quantified, and the type of contraceptive use was not specified. The CD4 counts and viral load for the study population were not collected, which could have allowed the possibility of ascertaining the relationship between the prevalent potential CVD risk factors and HIV progression in an entire female HIV population. This study was carried out in facilities where we received administrative approval and we therefore acknowledge the potential for selection bias. We did not study other risk factors for CVD such as hypertension, obesity, and hypercholesterolemia. Moreover, the study had some strengths. Most similar studies in Africa were conducted in single HIV treatment centers [3, 17, 21]. In addition, there is a paucity of studies that have examined the association between demographic characteristics and potential CVD risk factors such as smoking, alcohol, and contraceptive use among WLHIV. Data on these factors are not routinely collected for PLHIV [4]. Our study was a multi-center study with a large dataset of over 5000 participants. In comparison with single facility-based studies, this study provided more robust information and precision of estimates and the findings are generalizable to similar settings.

Conclusions

A low prevalence of smoking exists among women living with HIV on antiretroviral treatment. Older age, farming and being married are potential deterrents to lifestyle risk factors for cardiovascular diseases among this population. The goal is to improve HIV-related treatment efforts and outcomes for this population. Implementing interventions that could foster lifestyle behavioral modification among women living with HIV on antiretroviral treatment has the potential to reduce cardiovascular disease risks.

Acknowledgments

The authors acknowledge the support from the heads and staff of the participating health facilities, the patients, the staff of Caritas Nigeria, and the staff of the Center for Translation and Implementation Research (CTAIR) of the University of Nigeria, Nsukka, Enugu.

Data Availability

Our data involves human research participants of a vulnerable population. These are women in rural areas of Nigeria living with HIV and or HBV. They are prone to stigmatization in spite of data de-identification. As a result of this, there are ethical restrictions on making the data publicly available. Data access requests can be made to our institutional body. Name: Centre for Translation and Implementation Research, College of Medicine, University of Nigeria, Nsukka, Enugu State, Nigeria (UNN). Email: ctair@unn.edu.ng.

Funding Statement

EEE received funding support from Fogarty International Center of the US National Institutes of Health (NIH) (grant no. R21TW010252) and the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the NIH (grant numbers - R01HD087994 & R01HD087994-S1). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Henning R, Greene J. The epidemiology, mechanisms, diagnosis and treatment of cardiovascular disease in adult patients with HIV. Am J Cardiovasc Dis. 2023;13(2):101–21. [PMC free article] [PubMed] [Google Scholar]
  • 2.Shah A, Stelzle D, Lee K, Beck E, Alam S, Clifford S, et al. Global Burden of Atherosclerotic Cardiovascular Disease in People Living With HIV. Circulation. 2018;138(11):1100–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Edward A, Oladayo A, Omolola A, Adetiloye A, Adedayo P. Prevalence of traditional cardiovascular risk factors and evaluation of cardiovascular risk using three risk equations in nigerians living with human immunodeficiency virus. N Am J Med Sci. 2013;5(12):680–8. doi: 10.4103/1947-2714.123251 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Ekrikpo U, Akpan E, Ekott J, Bello A, Okpechi I, Kengne A. Prevalence and correlates of traditional risk factors for cardiovascular disease in a Nigerian ART-naive HIV population: a cross-sectional study. BMJ Open. 2018;8(7):e019664. doi: 10.1136/bmjopen-2017-019664 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Egbe C, Dakum P, Ekong E, Kohrt B, Minto J, Ticao C. Depression, suicidality, and alcohol use disorder among people living with HIV/AIDS in Nigeria. BMC Public Health. 2017;17(1):542. doi: 10.1186/s12889-017-4467-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Ogunmola O, Oladosu O, Olamoyegun A. Association of hypertension and obesity with HIV and antiretroviral therapy in a rural tertiary health center in Nigeria: a cross-sectional cohort study. Vasc Health Risk Manag. 2014;10:129–37. doi: 10.2147/VHRM.S58449 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Desalu O, Oluboyo P, Olokoba A, Adekoya A, Danburam A, Salawu F, et al. Prevalence and determinants of tobacco smoking among HIV patients in North Eastern Nigeria. Afr J Med Med Sci. 2009;38(2):103–8. [PubMed] [Google Scholar]
  • 8.Iliyasu Z, Gajida A, Abubakar I, Shittu O, Babashani M, Aliyu M. Patterns and predictors of cigarette smoking among HIV-infected patients in northern Nigeria. International Journal of STD & AIDS. 2012;23(12):849–52. doi: 10.1258/ijsa.2012.012001 [DOI] [PubMed] [Google Scholar]
  • 9.Ezeanolue E, Gbadamosi S, Olawepo J, Iwelunmor J, Sarpong D, Eze C, et al. An mHealth Framework to Improve Birth Outcomes in Benue State, Nigeria: A Study Protocol. JMIR Res Protoc. 2017;6(5):e100. doi: 10.2196/resprot.7743 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Gbadamosi S, Eze C, Olawepo J, Iwelunmor J, Sarpong D, Ogidi A, et al. A Patient-Held Smartcard With a Unique Identifier and an mHealth Platform to Improve the Availability of Prenatal Test Results in Rural Nigeria: Demonstration Study. J Med Internet Res. 2018;20(1):e18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Government of Benue State. Benue State government quick facts—2018. 2019. [Google Scholar]
  • 12.ICF NPCNNa. Nigeria Demographic and Health Survey 2013. Abuja, Nigeria, and Rockville, Maryland, USA: NPC and ICF; 2014. [Google Scholar]
  • 13.Mbalinda S, Kiwanuka N, Kaye D, Eriksson L. Reproductive health and lifestyle factors associated with health-related quality of life among perinatally HIV-infected adolescents in Uganda. Health and Quality of Life Outcomes. 2015;13(1):170. doi: 10.1186/s12955-015-0366-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Kumbeni M, Apanga P, Yeboah E, Kolog J, Awuni B. The relationship between time spent during the first ANC contact, home visits and adherence to ANC contacts in Ghana. Global Health Action. 2021;14(1):1956754. doi: 10.1080/16549716.2021.1956754 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Apanga P, Kumbeni M. Adherence to COVID-19 preventive measures and associated factors among pregnant women in Ghana. Trop Med Int Health. 2021;26(6):656–63. doi: 10.1111/tmi.13566 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Appiah L, Sarfo F, Huffman M, Nguah S, Stiles J. Cardiovascular risk factors among Ghanaian patients with HIV: A cross-sectional study. Clin Cardiol. 2019;42(12):1195–201. doi: 10.1002/clc.23273 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Elf JL, Variava E, Chon S, Lebina L, Motlhaoleng K, Gupte N, et al. Prevalence and Correlates of Smoking Among People Living With HIV in South Africa. Nicotine & Tobacco Research. 2017;20(9):1124–31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Kruse G, Bangsberg D, Hahn J, Haberer J, Hunt P, Muzoora C, et al. Tobacco use among adults initiating treatment for HIV infection in rural Uganda. AIDS Behav. 2014;18(7):1381–9. doi: 10.1007/s10461-014-0737-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Mdege ND, Shah S, Ayo-Yusuf OA, Hakim J, Siddiqi K. Tobacco use among people living with HIV: analysis of data from Demographic and Health Surveys from 28 low-income and middle-income countries. Lancet Glob Health. 2017;5(6):e578–e92. doi: 10.1016/S2214-109X(17)30170-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Tanimowo M, Akinboro A, Peter J, Alo A, editors. Smoking among PLWHIVs in Nigeria: Prevalence, demographic and socioeconomic aspects 2014. [Google Scholar]
  • 21.Mathebula R. Profile of selected cardiovascular disease risk factors among HIV patients on anti-retroviral therapy in Bushbuckridge Sub-district, Mpumalanga province: University of Limpopo; 2019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Gilmore A, Fooks G, Drope J, Bialous S, Jackson R. Exposing and addressing tobacco industry conduct in low-income and middle-income countries. Lancet. 2015;385(9972):1029–43. doi: 10.1016/S0140-6736(15)60312-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Baum M, Rafie C, Lai S, Sales S, Page J, Campa A. Alcohol use accelerates HIV disease progression. AIDS Res Hum Retroviruses. 2010;26(5):511–8. doi: 10.1089/aid.2009.0211 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Hahn J, Samet J. Alcohol and HIV disease progression: weighing the evidence. Curr HIV/AIDS Rep. 2010;7(4):226–33. doi: 10.1007/s11904-010-0060-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Duko B, Ayalew M, Ayano G. The prevalence of alcohol use disorders among people living with HIV/AIDS: a systematic review and meta-analysis. Substance Abuse Treatment, Prevention, and Policy. 2019;14(1):52. doi: 10.1186/s13011-019-0240-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Okoro U, Carey K, Johnson B, Carey M, Scott-Sheldon L. Alcohol Consumption, Risky Sexual Behaviors, and HIV in Nigeria: A Meta-Analytic Review. Curr Drug Res Rev. 2019;11(2):92–110. doi: 10.2174/1874473712666190114141157 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Bryant K, Nelson S, Braithwaite R, Roach D. Integrating HIV/AIDS and alcohol research. Alcohol Res Health. 2010;33(3):167–78. [PMC free article] [PubMed] [Google Scholar]
  • 28.Lucas G, Gebo K, Chaisson R, Moore R. Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS. 2002;16(5):767–74. doi: 10.1097/00002030-200203290-00012 [DOI] [PubMed] [Google Scholar]
  • 29.Agaba P, Meloni S, Sule H, Ocheke A, Agaba E, Idoko J, et al. Prevalence and predictors of severe menopause symptoms among HIV-positive and -negative Nigerian women. International Journal of STD & AIDS. 2017;28(13):1325–34. doi: 10.1177/0956462417704778 [DOI] [PubMed] [Google Scholar]
  • 30.Chinaeke E, Fan-Osuala C, Bathnna M, Ozigbu C, Olakunde B, Ramadhani H, et al. Correlates of reported modern contraceptive use among postpartum HIV-positive women in rural Nigeria: an analysis from the MoMent prospective cohort study. Reprod Health. 2019;16(1):2. doi: 10.1186/s12978-018-0663-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Osunkwo D, Nguku P, Mohammed A, Umeokonkwo C, Kamateeka M, Ibrahim M, et al. Prevalence of obesity and associated factors in Benue State, Nigeria: A population-based study. Ann Afr Med. 2021;20(1):9–13. doi: 10.4103/aam.aam_36_19 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Atama C, Okoye U, Odo A, Odii A, Okonkwo U. Belief System: A Barrier to the Use of Modern Contraceptives among the Idoma of Benue State, North Central Nigeria. Journal of Asian and African Studies. 2020;55(4):600–16. [Google Scholar]
  • 33.Obeng-Hinneh R, Kpoor A. Cohabitation and Its Consequences in Ghana. Journal of Family Issues. 2022;43(2):283–305. [Google Scholar]
  • 34.Aina S, Fadero O, Akintoye V, Adeleke O. Co-habitation as a correlate of self-esteem among undergraduate students of Adekunle Ajasin University Akungba-Akoko. Global Journal of Health Related Researches. 2021;3(2):211–8. [Google Scholar]
  • 35.Duko B, Toma A, Abraham Y. Alcohol use disorder and associated factors among individuals living with HIV in Hawassa City, Ethiopia: a facility based cross- sectional study. Substance Abuse Treatment, Prevention, and Policy. 2019;14(1):22. doi: 10.1186/s13011-019-0212-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Sherwood J, Lankiewicz E, Roose-Snyder B, Cooper B, Jones A, Honermann B. The role of contraception in preventing HIV-positive births: global estimates and projections. BMC Public Health. 2021;21(1):536. doi: 10.1186/s12889-021-10570-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Banigbe B, Audet C, Okonkwo P, Arije O, Bassi E, Clouse K, et al. Effect of PEPFAR funding policy change on HIV service delivery in a large HIV care and treatment network in Nigeria. PLoS One. 2019;14(9):e0221809. doi: 10.1371/journal.pone.0221809 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.National Population Commission (NPC) [Nigeria] and ICF. Nigeria Demographic and Health Survey 2018. Abuja, Nigeria, and Rockville, Maryland, USA: NPC and ICF.2019. [Google Scholar]
PLOS Glob Public Health. doi: 10.1371/journal.pgph.0002667.r001

Decision Letter 0

Abraham D Flaxman

20 Dec 2022

PGPH-D-22-01427

Risk factors for Cardiovascular Diseases and the Potential Influence of Sociodemographic characteristics: a cross-sectional evaluation of a large cohort of Women Living with HIV in north-central Nigeria

PLOS Global Public Health

Dear Dr. Ezeanolue,

Thank you for submitting your manuscript to PLOS Global Public Health. After careful consideration, we feel that it has merit but does not fully meet PLOS Global Public Health’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

==============================

Please submit your revised manuscript by Feb 03 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at globalpubhealth@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgph/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Abraham D. Flaxman, Ph.D.

Academic Editor

PLOS Global Public Health

Journal Requirements:

1. Please send a completed 'Competing Interests' statement, including any COIs declared by your co-authors. If you have no competing interests to declare, please state "The authors have declared that no competing interests exist". Otherwise please declare all competing interests beginning with the statement "I have read the journal's policy and the authors of this manuscript have the following competing interests:"

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does this manuscript meet PLOS Global Public Health’s publication criteria? Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe methodologically and ethically rigorous research with conclusions that are appropriately drawn based on the data presented.

Reviewer #1: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS Global Public Health does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Author review

Title: Risk factors for Cardiovascular Diseases and the Potential Influence of Sociodemographic characteristics: a cross-sectional evaluation of a large cohort of Women Living with HIV in north-central Nigeria

Suggestions and comments

Abstract: -

“Background: Age and education are known cardiovascular (CVD) risk factors in persons living with HIV (PLHIV).” This statement should be rewritten b/c when you say education is a known CVD risk factors it is not clear. Is it lack of information about CVDs? or having higher educational level, other?

“We performed regression analyses of the influence of sociodemographic characteristics on potential cardiovascular risk factors, namely, smoking, alcohol consumption, contraceptive use.” Why you didn’t consider other CVDs risk factors like obesity (high cholesterol level/ higher BMI, sedentary life/lack of regular physical activity, hypertension and …………...? Suggestion: if you have no reason/s justification add it as limitation.

On conclusion “Targeting educated WLHIV who are smokers and alcohol users in single relationships has the potential to foster the maintenance of viral suppression, reduce CVD and improve treatment outcomes in WLHIV.” Is scientifically acceptable to keep smokers and alcoholics in single relationships instead of looking for another solution? Suggestion: look up any written guidelines/ articles and rewrite it.

Introduction: -

Paragraph 2 and 3 lack coherence and need edition for English language.

Methods: -

“This study was carried out between June and December 2017.” Write the specific date of data collection.

“Independent variables included age (18-39/≥40years), education (educated/none), occupation (farmers/non-farmers), and having children (≥1/none).” What is your evidence to categorize this predictor variables? cite it.

Results: -

Write table footnote for those “other” in the result table.

Link result with table (cite result).

Clear explain which variables are analyzed by multivariate and what is the criteria to be analyzed by it after binary regression analysis i.e either indicate cut off P- value, or…...

The authors wrote, inferential statistics was obtained by computing bivariate /multivariate regression. Please write explicitly what type of regression (linear vs binary logistic) and model fitness/ procedures followed while you perform analysis.

Conclusion: -

Conclusion should be written based on the finding.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLOS Glob Public Health. doi: 10.1371/journal.pgph.0002667.r003

Decision Letter 1

Jianhong Zhou

7 May 2023

PGPH-D-22-01427R1

Risk factors for Cardiovascular Diseases and the Potential Influence of Sociodemographic characteristics: a cross-sectional evaluation of a large cohort of Women Living with HIV in north-central Nigeria

PLOS Global Public Health

Dear Dr. Ezeanolue,

Thank you for submitting your manuscript to PLOS Global Public Health. After careful consideration, we feel that it has merit but does not fully meet PLOS Global Public Health’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jun 19 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at globalpubhealth@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgph/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Jianhong Zhou

Staff Editor

PLOS Global Public Health

Journal Requirements:

1. Please send a completed 'Competing Interests' statement, including any COIs declared by your co-authors. If you have no competing interests to declare, please state "The authors have declared that no competing interests exist". Otherwise please declare all competing interests beginning with the statement "I have read the journal's policy and the authors of this manuscript have the following competing interests:"

Additional Staff Editor Comments (if provided): Please note we invited a new reviewer for this revision in addition to the previous reviewer. The new reviewer raised a few concerns which should be addressed.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: (No Response)

**********

2. Does this manuscript meet PLOS Global Public Health’s publication criteria? Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe methodologically and ethically rigorous research with conclusions that are appropriately drawn based on the data presented.

Reviewer #1: Yes

Reviewer #2: (No Response)

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: (No Response)

**********

4. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: (No Response)

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS Global Public Health does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: (No Response)

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLOS Glob Public Health. doi: 10.1371/journal.pgph.0002667.r005

Decision Letter 2

Miquel Vall-llosera Camps

17 Jul 2023

PGPH-D-22-01427R2

Potential Risk factors for Cardiovascular Diseases and associated Sociodemographic characteristics: a cross-sectional evaluation of a large cohort of Women Living with HIV in north-central Nigeria

PLOS Global Public Health

Dear Dr. Ezeanolue,

Thank you for submitting your manuscript to PLOS Global Public Health. After careful consideration, we feel that it has merit but does not fully meet PLOS Global Public Health’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Aug 16 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at globalpubhealth@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgph/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Miquel Vall-llosera Camps

Staff Editor

PLOS Global Public Health

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

**********

2. Does this manuscript meet PLOS Global Public Health’s publication criteria? Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe methodologically and ethically rigorous research with conclusions that are appropriately drawn based on the data presented.

Reviewer #2: Partly

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS Global Public Health does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: Dear Editor,

I have reviewed the revised manuscript entitled "Potential Risk factors for cardiovascular diseases and associated Sociodemographic characteristics: a cross-sectional evaluation of a large cohort of Women Living with HIV in north-central Nigeria".

The paper has undergone revisions to address the concerns raised during the initial review. The authors have been receptive to feedback and made some efforts to improve the manuscript.

In the revised paper, the authors have refrained from limiting their conclusion to smokers and alcohol users and emphasized the need for lifestyle behavioral modifications among women living with HIV on antiretroviral treatment.

The authors clarified that they meant “potential cardiovascular risk factors” and corrected this in the title and the manuscript.

The revised paper now includes confidence intervals for the estimates which makes it more informative.

The authors have added information about the chronic immune activation and inflammation associated with HIV and antiretroviral treatment, contributing to cardiovascular atherosclerosis.

The authors explained that age was dichotomized to enable comparability with earlier studies and referenced prior studies.

The authors included an explanation for the global null hypothesis test and how it is used to assess the fit of models, along with citations.

The authors updated the limitation section to include potential selection bias and the inability to study other major risk factors for CVD such as hypertension, obesity, and hypercholesterolemia.

Overall, the authors have made some efforts to address the issues raised in the initial review. However, I still have some concerns about the objective of the study and the connection between the findings and conclusion. For example, how can the following findings be useful? “Being a farmer negatively predicted alcohol consumption”, “Compared to being in a single relationship, being married positively predicted alcohol consumption”, “Education and having at least a child were independent risk factors for contraceptive use but older age and being a farmer were protective”. This seems to imply that we should encourage people to be a farmer and not get married. Furthermore, how could the conclusion reflect the findings more concretely?

I look forward to seeing the further revisions.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLOS Glob Public Health. doi: 10.1371/journal.pgph.0002667.r007

Decision Letter 3

Steve Zimmerman

20 Sep 2023

PGPH-D-22-01427R3

Potential Risk factors for Cardiovascular Diseases and associated Sociodemographic characteristics: a cross-sectional evaluation of a large cohort of Women Living with HIV in north-central Nigeria

PLOS Global Public Health

Dear Dr. Ezeanolue,

Thank you for submitting your manuscript to PLOS Global Public Health. After careful consideration, we feel that it has merit but does not fully meet PLOS Global Public Health’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Reviewer 2 still has some issues that need addressing - please see their comments below.

Could you please revise the manuscript to carefully address the concerns raised?

Please submit your revised manuscript by Oct 19 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at globalpubhealth@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgph/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Steve Zimmerman, PhD

PLOS Staff Editor

Journal Requirements:

1. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

2. Please send a completed 'Competing Interests' statement, including any COIs declared by your co-authors. If you have no competing interests to declare, please state "The authors have declared that no competing interests exist". Otherwise please declare all competing interests beginning with twhe statement "I have read the journal's policy and the authors of this manuscript have the following competing interests:"

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: (No Response)

**********

2. Does this manuscript meet PLOS Global Public Health’s publication criteria? Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe methodologically and ethically rigorous research with conclusions that are appropriately drawn based on the data presented.

Reviewer #2: (No Response)

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: (No Response)

**********

4. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: (No Response)

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS Global Public Health does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: (No Response)

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: Major Issues:

1. Contradictory Results on Alcohol Consumption:

The paper presents contradictory findings regarding the relationship between marital status and alcohol consumption. Line 173 states that being in a marital relationship increases the odds of alcohol consumption by 30%, while line 46 suggests that being single positively predicts alcohol consumption. This inconsistency needs to be addressed and clarified.

2. Unclear Relationship Between Contraceptive Use and Cardiovascular Risk:

The paper briefly mentions that oral contraceptives predispose individuals to cardiovascular diseases (CVD) by causing thrombosis but the study lacks data on the number of subjects who have taken oral contraceptives as opposed to other measures.

3. Data Selection and Potential Bias:

The study includes 5,430 complete-case observations out of a total of 8,825, without providing a rationale for this selection or discussing the potential consequences of dropping the remaining observations. To address this issue, the authors should either justify the exclusion of these observations or consider techniques like data imputation or sensitivity analysis.

Minor Issues:

1. Unrelated Conclusion on Viral Suppression:

The conclusion mentions the potential for lifestyle behavioral modifications to maintain viral suppression, a topic not covered in the study. This statement should either be removed or substantiated with relevant data or discussion.

2. Language Implying Causality:

Although the study admits it cannot establish causal relationships, phrases like "Being a farmer negatively predicted alcohol consumption" imply causality. The language should be revised to reflect the correlational nature of the findings.

3. Unclear Statement on p-value:

The statement "A p-value of less than 0.05 was considered statistically significant, indicating the models were fit" is unclear. The authors should clarify what is meant by "the models were fit" in the context of a p-value less than 0.05.

4. Irrelevant Information on Tobacco Industry:

The statement in line 209, "potentially, they are a target of the Tobacco industry," seems irrelevant to the study's focus and should be removed unless its relevance can be demonstrated.

5. Archaic Language:

The use of archaic words like "thrice" is not recommended in scientific writing. Please consider using more contemporary terms.

Summary:

The manuscript has several major and minor issues that need to be addressed before it can be considered for publication. Clarifying contradictory results, providing a rationale for data selection, and revising language to better align with the study's limitations are essential steps for improvement.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLOS Glob Public Health. doi: 10.1371/journal.pgph.0002667.r009

Decision Letter 4

Julia Robinson

6 Nov 2023

Potential Risk factors for Cardiovascular Diseases and associated Sociodemographic characteristics: a cross-sectional evaluation of a large cohort of Women Living with HIV in north-central Nigeria

PGPH-D-22-01427R4

Dear Prof Ezeanolue,

We are pleased to inform you that your manuscript 'Potential Risk factors for Cardiovascular Diseases and associated Sociodemographic characteristics: a cross-sectional evaluation of a large cohort of Women Living with HIV in north-central Nigeria' has been provisionally accepted for publication in PLOS Global Public Health.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact globalpubhealth@plos.org.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Global Public Health.

Best regards,

Julia Robinson

Executive Editor

PLOS Global Public Health

***********************************************************

Reviewer Comments (if any, and for reference):

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

**********

2. Does this manuscript meet PLOS Global Public Health’s publication criteria? Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe methodologically and ethically rigorous research with conclusions that are appropriately drawn based on the data presented.

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: No

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS Global Public Health does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: I have had the opportunity to review your manuscript titled "Potential Risk factors for Cardiovascular Diseases and associated Sociodemographic characteristics: a cross-sectional evaluation of a large cohort of Women Living with HIV in north-central Nigeria" through its various stages of revision. Thank you for your efforts in addressing the concerns and suggestions provided in the previous review rounds. I am pleased to see that the paper has improved considerably and now meets the standards of the journal.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

**********

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Response to reviewer comments.docx

    Attachment

    Submitted filename: Point by point response file_June 2023.docx

    Attachment

    Submitted filename: Point by point response file_August 2023.docx

    Attachment

    Submitted filename: Point by point response file_Sept 2023.docx

    Data Availability Statement

    Our data involves human research participants of a vulnerable population. These are women in rural areas of Nigeria living with HIV and or HBV. They are prone to stigmatization in spite of data de-identification. As a result of this, there are ethical restrictions on making the data publicly available. Data access requests can be made to our institutional body. Name: Centre for Translation and Implementation Research, College of Medicine, University of Nigeria, Nsukka, Enugu State, Nigeria (UNN). Email: ctair@unn.edu.ng.


    Articles from PLOS Global Public Health are provided here courtesy of PLOS

    RESOURCES